Bill Sponsors: NY A02904 | 2019-2020 | General Assembly

Bill Title: Prohibits certain insurance policies from requiring prior authorization for buprenorphine products, methadone and long acting injectable naltrexone for detoxification or maintenance treatment of substance use disorders.

Spectrum: Moderate Partisan Bill (Democrat 4-1)

Status: (Passed) 2019-12-31 - signed chap.748 [A02904 Detail]

Text: Latest bill text (Introduced) [HTML]

Sponsors

NameTypeSponsorshipDistrictFinancialEncyclopediaBiography
Assemblymember Dan Quart [D]PrimarySponsored BillsHD-073FollowTheMoneyBallotpediaVoteSmart
Assemblymember David Weprin [D]CosponsorSponsored BillsHD-024FollowTheMoneyBallotpediaVoteSmart
Assemblymember Robert Carroll [D]CosponsorSponsored BillsHD-044FollowTheMoneyBallotpediaVoteSmart
Assemblymember Diane Richardson [D]CosponsorSponsored BillsHD-043FollowTheMoneyBallotpediaVoteSmart
Assemblymember Christopher Tague [R]PrimarySponsored BillsHD-102FollowTheMoneyBallotpediaVoteSmart

Social Comments on NY A02904

feedback